TITLE

Expression of p53 Protein Before and After PUVA Treatment in Psoriasis

AUTHOR(S)
Hannuksela-Svahn, Anna; Pääkkö, Paavo; Autio, Pekka; Reunala, Timo; Karvonen, Jaakko; Vähäkangas, Kirsi
PUB. DATE
May 1999
SOURCE
Acta Dermato-Venereologica;5/27/99, Vol. 79 Issue 3, p195
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We investigated the effect of the potentially carcinogenic psoralen plus UVA radiation (PUVA) therapy on the expression of p53 in skin of psoriatic patients. p53 antibodies DO7 and Pab240, antibodies against PCNA and Ki67 and the avidin-biotin immunoperoxidase complex method were used in the immunohistochemical staining of biopsy samples from non-lesional and lesional skin of 23 patients who received either trioxsalen bath PUVA or oral 8-methoxypsoralen PUVA. Biopsies were taken before and after a PUVA course. A modest expression of p53 was seen in psoriatic lesions in 17/21 patients before any treatment, probably as a physiological reaction to the hyperproliferation. Both p53 and the proliferation markers Ki67 and PCNA followed the same pattern, being more frequent in psoriatic lesions than in non-lesional skin. Exposure to PUVA induced an increase in p53 expression in non-lesional skin in 14/19 patients, putatively as a response to DNA damage caused by PUVA. In psoriatic lesions about half of the patients showed increased and half decreased expression of p53. The latter finding might be explained by decreased proliferation activity of the healing epidermis. In conclusion, p53 nuclear positivity in non-lesional skin after PUVA treatment is likely to be induced by DNA damage caused by PUVA, while in psoriatic lesions it could be a result of the combined effect of decreasing epidermal proliferation and DNA-damage.
ACCESSION #
5122353

 

Related Articles

  • Triple Helix-Mediated Inhibition of Gene Expression Is Increased by PUVA. Besch, Robert; Marschall, Christoph; Schuh, Theda; Giovannangeli, Carine; Kammerbauer, Claudia; Degitz, Klaus // Journal of Investigative Dermatology;May2004, Vol. 122 Issue 5, p1114 

    The combination of psoralens with UVA is used as PUVA therapy for psoriasis and other skin diseases. UVA-induced psoralen/DNA photoadducts act via suppression of DNA replication and cell proliferation, but do not sufficiently repress gene transcription. To explore whether PUVA may also be used...

  • Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity. Deeni, Yusuf Y.; Ibbotson, Sally H.; Woods, Julie A.; Wolf, C. Roland; Smith, Gillian // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background: There are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that variability in cutaneous P450...

  • Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Bowcock, M.; Shannon, William; Du, Fenghe; Duncan, Jill; Cao, Kai; Aftergut, Kent; Catier, Jennifer; Fernandez-Vina, A.; Menter, Alan // Human Molecular Genetics;Aug2001, Vol. 10 Issue 16 

    Approximately 2% of the Caucasian population is affected by psoriasis (PS); a chronic inflammatory skin disease triggered by both genetic and environmental risk factors. In addition to a major contribution from the HLA class I region, PS susceptibility loci have been mapped to a number of...

  • Influence of prophylactic photochemotherapy on incidence of relapse of psoriasis cleared initially with dithranol. Marks, Janet M.; Lawrence, C.M.; Corbett, M.; Coburn, P.; Parker, S.; Shuster, Sam // British Medical Journal (Clinical Research Edition);1/14/1984, Vol. 288 Issue 6411, p95 

    Investigates the effect of psoralens and ultraviolet A on patients with psoriasis. Use of dithranol in treating the disease; Difference in the incidence of relapse between time intervals; Basis of the dosage on skin type of patients.

  • 5-Methoxypsoralen: A Review of its Effects in Psoriasis and Vitiligo. McNeely, W.; Goa, K.L. // Drugs;Oct1998, Vol. 56 Issue 4, p667 

    5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo. In patients and volunteers, PUVA 5-methoxypsoralen causes a dose-related increase in cutaneous...

  • Plasma and Skin Concentration of 5-Methoxypsoralen in Psoriatic Patients After Oral Administration. Zucchi, Alfredo; Raho, Ersilia; Marconi, Bettina; Nicoli, Sara; Santini, Marcello; Allegra, Fulvio; Colombo, Paolo; Bettini, Ruggero; Santi, Patrizia // Journal of Investigative Dermatology;Aug2001, Vol. 117 Issue 2, p379 

    The aim of this work was to investigate the distribution of 5-methoxypsoralen in the skin after oral administration of the drug and to examine the correlation between skin and plasma concentrations. 5-Methoxypsoralen skin concentration was measured in both healthy and psoriatic sites of 10...

  • Committee Scrutinizes the Links. Jeter Between Melanoma and PUVA Therapy, Darlene // Dermatology Times;Apr98, Vol. 19 Issue 4, p6 

    Examines the liabilities of psoralen ultraviolet A (PUVA) therapy in the treatment of Psoriasis. Responsibilities of the committee formed by the National Psoriasis Foundation to study the relationship between melanoma and PUVA therapy; Results released by the committee concerning the...

  • Treatment of Peripheral Blood Mononuclear Cells with 8-Methoxypsoralen plus Ultraviolet A Radiation Induces a Shift in Cytokine Expression from a Th1 to a Th2 Response. Klosner, Gabriele; Trautinger, Franz; Knobler, Robert; Neuner, Peter // Journal of Investigative Dermatology;Mar2001, Vol. 116 Issue 3, p459 

    Summary Treatment with 8-methoxypsoralen plus ultraviolet A radiation and extracorporeal photochemotherapy (photopheresis) are widely used for the treatment of psoriasis and other inflammatory skin diseases, graft-versus -host disease, and mycosis fungoides. As the ratio of Th1 and Th2 cells...

  • PUVA.  // British Medical Journal;7/1/1978, Vol. 2 Issue 6129, p2 

    Examines the use of psoralen high-intensity long-wave ultraviolet radiation in the treatment of psoriasis. Effectivity of the PUVA; Advantages in using PUVA: List of side effects associated with PUVA.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics